CE3F4

Overview

CE3F4 is a selective antagonist of exchange protein directly activated by cAMP ( Epac1 ), with IC 50 s of 10.7 μM and 66 μM for Epac1 and Epac2(B), respectively.

Application

Products | Products > Disease Areas > Liver Cancer | Products > Disease Areas > Leukemia/Lymphoma/Myeloma | Products > Disease Areas > Blood Disease | Products > Disease Areas > Pancreatic Cancer | Products > Disease Areas > Cardiovascular Disease | Products > Disease Areas > Cancer | Products > Disease Areas > Blood or Cardio-cerebrovascular Disease | Products > Disease Areas > Digestive System Disease | Products > Disease Areas > Colorectal Cancer | Products > Disease Areas > Digestive System Cancer | Products > Signaling Pathways > GPCR/G Protein | Products > Signaling Pathways > MAPK/ERK Pathway | Products > Research Areas > Cardiovascular Disease | Products > Signaling Pathways > Ras

Product Information

• Catalog No.: HY-108539
• CAS No.: 143703-25-7
• Molecular Formula: C11H10Br2FNO
• Molecular Weight: 351.01
• Purity: 98.85%
• Storage: -20°C, stored under nitrogen * In solvent : -80°C, 6 months; -20°C, 1 month (stored under nitrogen)
• Solubility: ≥ 2.5 mg/mL (7.12 mM); Clear solution
• Availability: In-stock

Source

Original product source